A national network of scientists and people’s science movements has expressed concern over the World Health Organisation (WHO) not granting emergency use listing for ICMR-Bharat Biotech’s Covaxin. It warned that India looked set to repeat the blunders it committed in the Covaxin approval process in the way it was approving Zydus Cadilla’s ZyCov-D three-dose vaccine for those 12 years and older.
Read more here:: India News Times